Back to News
Market Impact: 0.28

Jefferies lowers Vistra Energy stock price target on valuation By Investing.com

VSTSMCIAPP
Analyst InsightsCompany FundamentalsCorporate EarningsM&A & RestructuringCorporate Guidance & OutlookEnergy Markets & Prices
Jefferies lowers Vistra Energy stock price target on valuation By Investing.com

Jefferies cut Vistra Energy’s price target slightly to $190 from $192 while reiterating a Buy, implying about 35% upside from the current $144 share price. The firm highlighted a compelling valuation at 7.3x EV/EBITDA and roughly 14% fiscal 2028 free cash flow yield, despite PJM reform overhangs and a 35% decline from the September 2025 high of $219.82. Recent Q1 2026 results also topped estimates, with EPS of $1.31 versus $1.28 consensus and revenue of $5.64 billion versus $5.62 billion.

Analysis

The market is treating VST like a clean power story, but the real driver is duration-of-cash-flow under regulatory uncertainty. If the contracted EBITDA base is still modest, the equity is effectively a levered call option on power scarcity plus data-center load growth, and that is exactly why the stock can stay cheap longer than fundamentals suggest: investors are demanding a higher discount rate for policy risk than for operating risk. The second-order winner is not just VST’s generation stack, but any merchant-heavy fleet with baseload exposure and optionality to incremental nuclear/thermal monetization. Competitors without a retail book or without a pathway to contracted load are more exposed to PJM reform headlines, because they lack the same self-help from customer diversification. Conversely, this environment pressures pure-play renewables and lower-margin peakers that need stable capacity pricing but do not have the same contract visibility. The key near-term catalyst is not another earnings beat; it is whether PJM reform language narrows the range of outcomes on capacity pricing over the next 1-3 months. If reforms are constructive, the stock can rerate quickly because the market is currently pricing in a worst-case regulatory read-through. If they disappoint, the downside is likely sharper than the upside because the name has already de-rated materially and is now being owned as a value recovery trade rather than a growth compounder. Contrarian view: consensus is focused on upside from data-center and nuclear optionality, but may be underestimating the timing mismatch between announced contracts and realized EBITDA. The stock can look optically cheap on 2028 FCF, yet if financing costs stay elevated and policy clarity stalls, the equity may remain range-bound for quarters. That makes this a better expressed as a timed catalyst trade than a blind long on ‘cheapness.’